The Covid-19 shot may have further-reaching benefits than previously thought, as mRNA vaccines appear to help increase the ...

What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 6.9% in the afternoon session after ongoing ...

Cancer patients who got an mRNA COVID vaccine within a few months of their immunotherapy lived longer than those who did not, health records show.

The study, published in the journal Nature, showed the jabs provided an immunity boost that helped extend survival for ...

Small study looks only at a cardiac biomarker; findings are in line with reduced myocarditis risk in mRNA COVID vaccines ...

Researchers found that COVID-19 mRNA vaccines significantly increased survival in lung and skin cancer patients undergoing ...

ATLANTA — Moderna’s respiratory syncytial virus vaccine is safe and effective for adults who have received a solid organ ...

A new mRNA platform targets tumors with precision, limits side effects, and converts immune-silent cancers into responsive ...

A study published in "Nature" shows the mRNA vaccine could extend the lives of people undergoing cancer treatment.

The observation that mRNA vaccines can sensitize tumors to immunotherapy has researchers eager to test how mRNA’s ability to activate the immune system could be harnessed in oncology.

Moderna (MRNA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...